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Abstract
Successful pregnancy necessitates that the human uterus is maintained in a relaxed, qui-
escent state for the majority pregnancy, before ultimately transforming to a contractile 
phenotype capable of powerful, coordinated contractions to facilitate parturition. The 
exact mechanisms that regulate this transition are yet to be fully understood, and as such, 
we still do not understand the molecular mechanisms that trigger the onset of human 
labor. This is in large part due to the ethical considerations associated with human preg-
nancy, which, outside of clinical trials, primarily limits human studies to in vitro investi-
gations on cell lines and biopsied tissues. Researchers have therefore devised numerous 
model systems for investigating pregnant human uterine smooth muscle, which have 
played vital roles in elucidating the fundamental biology and key regulatory pathways 
that underpin the transition from quiescence to contractility. This chapter describes in 
detail, those methods and model systems used to study pregnant human uterine smooth 
muscle, and explores the challenges associated with these model systems.
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1. Introduction
Parturition requires that myometrial smooth muscle undergo a phenotypic transition, remain-
ing quiescent for the majority of gestation and then transforming to a tissue capable of generat-
ing forceful, coordinated contractions to expel the fetus and the placenta [1–3]. Characterizing 
the regulation of key myometrial genes is essential to understanding normal human birth, as 
well as obstetric complications, including preterm labor. Outside of clinical trials, researchers 
are primarily limited to observational studies of human pregnancy, and as such, rely heavily 
on in vitro models of the uterus for performing investigational studies. Human cell cultures 
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are a valuable in vitro tool, used to gain insight into numerous physiological and pathological 
processes; however, concerns have been raised about the lifespan of cultured primary cells, as 
well as their ability to remain representative of the tissue of origin. In an attempt to address 
the limited lifespan of cultured primary cells, immortalized cell lines have been developed by 
transfecting telomerase expression vectors into primary cells. Nevertheless, multiple studies 
have shown that immortalization could cause fundamental changes in the cells, and therefore 
many studies opt to use primary cells at low passage numbers instead. More recently, 3D cell 
culture models have been developed to more closely mimic the in vivo environment of the 
cells. Although these 3D cell cultures recreate tissue environments, they still have multiple 
limitations, such as cost, long production times and often the need for specialized equipment. 
Incubation of tissue ex vivo as small pieces (explants) or strips models the in vivo phenotype 
more closely and has emerged as a popular experimental model for interrogating myometrial 
biology. Nonetheless, recent evidence indicates that pregnant human smooth muscle tissue 
undergoes rapid phenotypic changes during these ex vivo studies. The consequences are con-
siderable in that findings made using ‘non-laboring’ tissue may in fact have been attained 
using tissue that had spontaneously transitioned to a laboring phenotype throughout the 
course of the study. Model systems of myometrium that are in a state of flux have the capac-
ity to confound results when researchers seek to elucidate the trigger(s) for labor. This chap-
ter describes in detail, methods and model systems used to study pregnant human uterine 
smooth muscle, and explores the challenges associated with these model systems.
2. Preterm birth
Preterm birth is defined by the World Health Organization as birth occurring before 37 com-
pleted weeks of gestation [4]. Estimates of global rates of preterm births suggest that of the 
135 million live births worldwide in 2010, 14.9 million babies were born preterm, representing 
a preterm birth rate of 11.1% [5, 6]. In recent decades, the rate of preterm birth has continued 
to rise in most countries, despite advances in medical technology as well as the introduction 
of medical interventions designed to reduce preterm birth [5, 7–9]. This is alarming given that 
preterm birth is a leading cause of neonatal death, responsible for 44% (2.761 million) of the 
6.3 million deaths of children who died before age 5 years in 2013 [10]. Additionally, survivors 
of preterm birth often suffer both short- and long-term morbidities. Short-term morbidities 
include respiratory distress syndrome, necrotizing enterocolitis, intraventricular hemorrhage, 
and patent ductus arteriosus, while long-term morbidities include cerebral palsy, mental retar-
dation and learning impairment, visual and hearing problems, as well as possible increased 
risk of cancer [11–13]. These translate into enormous economic and societal cost [14]. The 
economic costs include immediate expenses associated with neonatal intensive care, as well 
as the long-term costs of ongoing management of disabilities and diseases [14, 15]. The soci-
etal costs include families experiencing the sudden loss of a newborn, or stressful hospital-
ization of newborns that often extends for months, followed by lifelong support of children 
with varying severities of ongoing disease(s) [14]. Achieving decreased rates of preterm birth 
with improved neonatal outcomes would therefore have enormous implications at the com-
munity level. Nevertheless, little progress has been made addressing preterm birth due to a 
poor understanding of the underlying mechanisms that initiate myometrial contractions. As 
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such, the development of in vitro methods and model systems for studying pregnant human 
myometrium is critical to determining the regulatory mechanisms that underpin the onset of 
both term and preterm labor.
3. Human myometrial smooth muscle cell culture models
Human myometrial smooth muscle cell (SMC) cultures have been used extensively to study 
myometrial biology and researchers have been able to elucidate many aspects of fundamental 
biology, such as the regulation of gene expression and signaling pathways. In SMC cultures, 
myometrial biopsies are typically obtained from the lower uterine segment of term singleton 
pregnancies during Cesarean section, dissected into 1 mm3 pieces and washed in a saline 
solution, such as Hanks’ Balanced Salt Solution, to remove excess blood. Myometrial pieces 
are enzymatically digested down to single cells (collagenase XI, collagenase IA). The diges-
tion suspension is then repeatedly passed through a fine sterile pipette to disperse myome-
trial cells. Enzymatic digestion is stopped by addition of 5% fetal bovine serum (FBS) to the 
medium. Myometrial cells are then purified using a cell sieve (pore diameter of ~70 μm) and 
centrifugation, before ultimately being plated into culture flasks containing smooth muscle 
medium, supplemented with 5% FBS and antibiotic-antimycotic. The isolated SMCs are typi-
cally assessed by Trypan blue exclusion method to determine cell viability. The myometrial 
SMCs are incubated at 37°C in a humidified atmosphere of 95% air and 5% CO
2
 for growth 
and expansion, as required (Figure 1).
Casey et al. [16] established first human myometrial SMCs in monolayer culture in 1984 
and reported that the cells were stable for up to a year with no morphological changes. 
Nevertheless, concerns were raised about the lifespan of cultured primary cells, and Hayflick 
and Moorhead [17] reported that cell populations are only capable of dividing a fixed number 
of times before reaching replicative senescence. In an attempt to address the limited lifespan 
of cultured primary cells, numerous strategies have been used to develop myometrium-like 
cell lines with greater proliferative potential.
Perez-Reyes et al. [18] immortalized human SMCs in vitro by infecting the cells with a retroviral 
vector that contained the E6/E7 open reading frames of human papillomavirus type 16. The 
immortalized SMCs had significantly increased growth rates, compared to non-immortalized 
control cells, and there were no signs of senescence with long-term passage [18]. These first 
retrovirally infected SMC lines can be in continuous tissue culture for more than 1 year [18]. 
However, in addition to having an increased growth rate, cell size was decreased and there were 
alterations in α-smooth muscle actin (α-SMA) filament distribution and staining intensity [18].
Previous studies have demonstrated that human telomerase reverse transcriptase (hTERT) can 
stabilize telomere length and prolong cellular proliferative capacity [19–23]. Therefore, Condon 
et al. [24] developed a SMC line from hTERT-infected myometrial cells to investigate the complex 
molecular, hormonal and cellular processes associated with the myometrium. hTERT-infected 
myometrial cells were able to be in continuous culture for more than 10 months [24]. Furthermore, 
these cells exhibited a number of markers of SMCs, including α-SMA, smoothelin, h-caldesmon 
and calponin expression, as well as genes associated with reproductive function and parturition, 
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including the oxytocin receptor (OXTR), estrogen receptor 1 (ESR1) and progesterone receptor 
(PGR) [24]. Additionally, hTERT-infected myometrial cells were responsive to both oxytocin and 
estrogen, thus further implying that they are a suitable in vitro model for investigating the molec-
ular mechanisms that regulate uterine SMC gene expression [24].
Since hTERT cell lines have become popular among researchers, Soloff et al. [25] compared 
phenotypes of three telomerase-immortalized myometrial cell lines with the matching cells 
in primary culture, from which the immortalized cells were derived. Out of more than 
10,000 expressed genes, only 1% of genes consistently exhibited expression changes in the 
telomerase-immortalized cell lines [25]. Furthermore, the comparison between primary and 
telomerase-immortalized cells revealed no significant differences in signaling pathways, such 
as epidermal growth factor (EGF)-stimulated phosphorylation of the EGF receptor, insulin-
stimulated Akt phosphorylation, oxytocin and lysophosphatidic acid-stimulated extracellular 
signal-regulated kinase (ERK) 1 and 2 phosphorylation, myosin light chain (MYL) phosphory-
lation, and interleukin-1 induction of IκBα degradation [25]. Although this study found no 
significant difference between immortalized and primary cell lines, it has been suggested that 
immortalization could cause fundamental changes in the cells [26], and as such many studies 
use primary cells only at low passages (passage five and lower) [27].
Mosher et al. [26] established primary cultures of human myometrial cells isolated from 
paired upper and lower segment uterine biopsies for 10 passages and determined the expres-
sion of smooth muscle markers, fibroblast markers, contractile proteins or labor-associated 
Figure 1. Human myometrial smooth muscle cell culture model. Human myometrial samples are obtained from lower 
uterine segment during elective Cesarean section of singleton pregnancies. The samples are cleared of serosa, fibrous 
or damaged tissue and visible blood vessels, and dissected into small pieces. The myometrial pieces are enzymatically 
digested down to single cells (collagenase XI, collagenase IA). Myometrial cells are then purified using a cell sieve and 
plated into culture plates containing smooth muscle medium (95% O
2
/5% CO
2
/37°C). The cultured myometrial cells are 
then subjected to desired treatments or experimental conditions, after which cells can be snap frozen or preserved for 
subsequent analyses.
Muscle Cell and Tissue - Current Status of Research Field312
proteins over time. It was found that both upper and lower segment human myometrial cells 
stably expressed smooth muscle markers (α-SMA, calponin, caldesmon, tropomyosin) and 
fibroblast markers (vimentin, 1B10) to at least 10 passages [26]. Interestingly, comparison of 
paired upper and lower segment myometrial cells revealed that mRNA levels for Connexin 
43 (GJA1), Prostaglandin-endoperoxide synthase 2 (PTGS2) and vimentin (VIM) were sig-
nificantly higher in lower segment cells compared to upper segment cells [26]. These find-
ings supported the concept of a functional regionalization of the upper and lower segment 
of the human uterus and indicated that both upper and lower segments should be exam-
ined in order to garner maximum insight into the mechanisms underlying human parturi-
tion. Furthermore, both cell populations retained their ability to respond to inflammatory 
stimuli from passage 1 through to passage 10, as demonstrated by increased expression of 
PTGS2 and release of the pro-inflammatory chemokine, CXCL8, following treatment with 
the interleukin-1β (IL-1β) [26]. Mosher et al. [26] concluded that primary myometrial cells are 
viable and responsive for at least 10 passages, and therefore represent a useful tool for inves-
tigating human parturition. Nevertheless, this study did not to compare each passage with 
the fresh tissue to ascertain whether the cells were truly representative of the tissue of origin.
Recently, a study by Zaitseva et al. [28] compared gene expression profiles between myometrial 
and fibroid tissues, as well as SMCs isolated from these tissues that were cultured for up to 
three passages. It was found that 2055 genes were differentially expressed between all groups 
(fresh myometrial tissue, fresh fibroid tissue, myometrial SMCs at passage 0, fibroid SMCs 
at passage 0, myometrial SMCs at passage 3 and fibroid SMCs at passage 3) [28]. A total of 
128 genes were found to be significantly different between fresh myometrial and fibroid tis-
sues [28]. More than 1100 genes were significantly different between fresh tissues and cultured 
SMCs, with 648 genes common between both myometrial and fibroid SMCs at passage 0 and 
passage 3 [28]. These findings indicate that culture conditions significantly changed the gene 
expression profile of myometrial and fibroid SMCs, decreasing differences between the cells in 
vitro compared to the cells in vivo [28]. Furthermore, Zaitseva et al. [28] examined expression of 
ESR1 and PGR in fresh myometrial and fibroid tissues, as well as cultured SMCs. Expression 
of both receptors was significantly decreased in cultured SMCs compared to fresh tissues [28]. 
Zaitseva et al. [28] concluded that myometrial and fibroid cell cultures provide a vital tool to 
study the uterus, but nevertheless, in vitro studies must be carefully planned and assessed to 
provide significant results.
4. Stretch-based culture systems
Throughout normal pregnancy the uterus increases several-fold in size by both hyperplasia 
and hypertrophy to accommodate the growing fetus and placenta [29, 30]. In 1982, Manabe 
et al. [31] applied mechanical stretching of the uterus to seven term patients who were not in 
labor by inserting and inflating a 150 mL rubber balloon. All seven patients showed significant 
cervical softening, as well as initiation and progress of labor [31]. Furthermore, analysis of 
amniotic fluid revealed that the uterine stretch initiated increased release of prostaglandin (PG) 
F (PGF) [31]. Based on these results, the in vitro model of pregnancy-induced uterine stretch has 
been used in multiple studies to investigate the effect of stretch on human SMCs [29, 30, 32, 33].
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The in vitro model of pregnancy-induced uterine stretch involves growing SMCs in 6-well cul-
ture plates with a flexible collagen growth surface. The plates are placed in a computer-driven 
Flexercell strain unit, which generates a vacuum in order to deform the flexible growth surface. 
Through deforming the growth surface, cultured cells can be subjected to static stretch of 6, 11 or 
16% for 1 or 6 h (Figure 2). Using this model, Sooranna et al. [30] investigated the effect of stretch 
on PG synthesis in non-pregnant, pregnant non-laboring and pregnant laboring primary human 
SMCs. Non-pregnant and pregnant laboring SMCs had significantly higher PTGS2 mRNA lev-
els than pregnant non-laboring SMCs [30]. When stretch was applied, PTGS2 mRNA expression 
significantly increased in all three groups [30]. In additional studies using pregnant non-laboring 
SMCs, 6 h of stretch increased PTGS2 protein levels, increased PGI
2
 metabolite and PGE
2
 con-
centrations in the media, as well as decreased PGF2α metabolites in the media [30]. Furthermore, 
following stretch there was increased activator protein-1 (AP-1) nuclear protein DNA binding 
activity in pregnant non-laboring SMCs [30]. These results provided evidence that increased 
PTGS2 activity, following stretch of human myocytes, occurs through activation of the AP-1 sys-
tem [30].
Terzidou et al. [32] investigated the effect of stretch on the expression of OXTR mRNA and DNA 
binding of AP-1, CCAAT/enhancer binding protein (C/EBP)β, and nuclear factor-κB (NF-κB) 
transcription factors in non-pregnant, pregnant non-laboring and pregnant laboring primary 
Figure 2. Flexercell stretch-based culture system. Primary myometrial cells, prepared from myometrial biopsies, are 
plated into 6-well culture plates with a flexible collagen growth surface (95% O
2
/5% CO
2
/37°C). The plates are placed 
in a computer-driven Flexercell strain unit capable of generating a vacuum that deforms the flexible growth surface. 
Through deforming the growth surface, cultured cells can be subjected to varying degrees of stretch, as well as treated 
with exogenous agents. The cells can then be snap frozen or preserved for subsequent analyses.
Muscle Cell and Tissue - Current Status of Research Field314
human SMCs. Pregnant laboring SMCs had significantly higher OXTR mRNA expression com-
pared to non-pregnant and pregnant non-laboring SMCs [32]. Application of stretch to pregnant 
non-laboring human myocytes significantly increased OXTR mRNA levels and increased OXTR 
promoter activity [32]. Conversely, stretching of non-pregnant and pregnant laboring human 
myocytes did not affect OXTR mRNA levels [32]. Increased promoter activity within the preg-
nant non-laboring cells was associated with increased DNA binding of C/EBPβ and AP-1 [32]. 
Overexpression of C/EBPβ led to increased OXTR promoter activity [32]. Based on these results, 
the authors concluded that stretch of pregnant non-laboring SMCs increases OXTR expression 
through increased C/EBPβ DNA binding [32]. More importantly, these results imply that stretch 
contributes to the increase in OXTR expression at the time of labor during human parturition [32].
Loudon et al. [29] investigated the effect of stretch on the expression of interleukin-8 (IL-8) in 
non-pregnant, pregnant non-laboring and pregnant laboring primary human SMCs. Previous 
studies have shown that labor is associated with increased synthesis of pro-inflammatory 
cytokines, including IL-8 [34, 35]. Pregnant laboring SMCs have significantly higher IL-8 
mRNA expression than non-pregnant and pregnant non-laboring SMCs [29]. The applica-
tion of stretch, via the Flexercell strain unit, significantly increased IL-8 mRNA expression 
in myocytes from all three groups [29]. Furthermore, stretch-induced increase in IL-8 mRNA 
expression was concurrent with increased IL-8 levels in the culture supernatant, as well as 
increased promoter activity [29].
Previous pregnancy-induced uterine stretch studies have shown that PTGS2 and IL-8 mRNA 
expression increases in vitro following mechanical stretch of uterine SMCs [29, 30]. Therefore, 
Sooranna et al. [33] further investigated whether IL-1β and mechanical stretch increase the 
myometrial expression of PTGS2 and IL-8 through mitogen-activated protein kinase (MAPK) 
activation, and whether these effects were synergistic. Pregnancy-induced uterine stretch 
increased PGHS-2 and IL-8 mRNA expression through ERK1/2 and p38 MAPK pathways 
[33]. Likewise, IL-1β increased PGHS-2 mRNA expression through ERK1/2 and p38 MAPK 
pathways [33]. However, IL-1β increased IL-8 mRNA expression through the ERK1/2 path-
way only [33]. Furthermore, there was no evidence of a synergistic effect of IL-1β and stretch 
on PTGS2 and IL-8 mRNA expression [33].
These studies using the in vitro model of pregnancy-induced uterine stretch demonstrated that 
mechanical stretch is able to increase expression of various genes. Namely, stretch increased 
PTGS2 and IL-8 expression through MAPK-dependent signaling, while OXTR expression was 
increased through a MAPK-independent mechanism [29, 30, 32, 33]. As such, Lei et al. [36] 
investigated whether progesterone was able to inhibit stretch-induced MAPK activation, as 
well as PTGS2 mRNA expression and protein synthesis [36]. Pre-incubation of primary SMCs 
with progesterone did not inhibit stretch-induced ERK1/2 activation or PTGS2 mRNA expres-
sion [36]. Additionally, it was determined that mechanical stretch did not modify the ability of 
progesterone to modulate progesterone-responsive gene expression, activate a progesterone 
response element or inhibit IL-1β-driven PTGS2 mRNA expression [36]. Mechanical stretch 
was found to decrease PR-T and PR-B mRNA expression via NF-κB activation; however, 
stretch does not appear to inhibit progesterone action [36]. These findings, derived from the in 
vitro model of pregnancy-induced stretch, suggest that stretch is not responsible for the func-
tional progesterone withdrawal observed with the onset of human labor [36].
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In a similar approach, Dalrymple et al. [37] used the Flexercell strain unit to subject SMCs to 
tonic stretch of 25% for 1, 4 and 14 h. Mechanical stretch for 14 h increased basal calcium entry, 
as well as cyclopiazonic acid-induced calcium/manganese entry [37]. Furthermore, prolonged 
tonic stretch increased transient receptor potential canonical (TRPC) channel gene expression 
and protein levels [37]. TRPC proteins are known components of store-operated calcium entry 
and are expressed in human myometrium during pregnancy [38–40]. Since an increase of cal-
cium entry leads to increased contractility of smooth muscle, this study reveals a possible path-
way by which uterine function can be modified in response to the growing fetus throughout the 
pregnancy [37].
The studies discussed thus far have utilized human primary SMCs to investigate the effects 
of stretch. Recently, Lee et al. [41] used hTERT cells to investigate whether stretch facilitates 
peripheral leukocyte extravasation into the term myometrium through the release of various 
cytokines by uterine myocytes. In the study, hTERT cells were grown on flexible-bottom cul-
ture plates and static stretch of 25% was applied for 24 h [41]. It was found that mechanical 
stretch resulted in secretion of multiple cytokines and chemokines, including IL-6, IL-12p70, 
migration inhibitory factor (MIF), C-X-C motif ligand (CXCL) 8, CXCL1, granulocyte colony-
stimulating factor (G-CSF), vascular endothelial growth factor (VEGF), basic fibroblast growth 
factor (bFGF) and platelet-derived growth factor subunit B (PDGF-bb) [41]. Furthermore, 
stretch-induced cytokines increased leukocyte adhesion to the endothelium of the surround-
ing uterine microvasculature by stimulating the expression of endothelial cell adhesion mol-
ecules, as well as by directing the transendothelial migration of peripheral leukocytes [41]. 
These results provide evidence for the mechanical regulation of leukocyte migration from the 
uterine blood vessels toward the myometrium [41].
Up until now, majority of in vitro cell-based assays have utilized traditional two-dimensional 
(2D) culture, where cells are grown as a monolayer on a flat surface. Although 2D culture has 
proven to be an effective method for cell-based studies, and researchers have been able to 
elucidate many aspects of fundamental biology, the limitations of 2D culture have gradually 
been recognized. In the in vivo environment, the majority of cells are surrounded by other 
cells and extracellular matrix in a three-dimensional (3D) arrangement. In recognition of this, 
studies are increasingly exploring the application of 3D culture techniques in an effort to more 
closely mimic the in vivo environment of the cells.
5. 3D culture models
3D culture is the growing of cells in an artificial environment that permits cells to grow and 
interact with their surroundings in all three dimensions. Often this involves growing SMCs on 
or in a scaffold comprised of extracellular matrix proteins, which is designed to resemble the 
in vivo tissue environment. Through mimicking the in vivo environment, the scaffold permits 
cells to attach, attain the right configuration and migrate or differentiate. Additionally, the 3D 
platform can provide cells with an environment comprising the growth factors, cytokines and 
some extracellular matrix proteins produced by the cells during their growth. Over the past 
several years, immense effort has been put into the creation of various 3D cell culture plat-
forms, for instance protein gels such as Matrigel and collagen, which reconstruct extracellular 
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matrix composition [42]; polymer scaffolds, which mimic tissue structure and material prop-
erties [43]; hanging drop spheroids, which use water tension in liquid droplets to aggregate 
cells into spheroids [44–46]; round bottom plates, which use plate geometry to aggregate cells 
in spherical bottom wells [46]; as well as nano-patterned plates. Although these 3D cell cul-
ture platforms recreate tissue environments to varying degrees, they still have technical and 
cost limitations; for instance, long production times, the need for specialized equipment, as 
well as the produced 3D structures primarily being limited to spheroids, as opposed to more 
complex shapes that would better enable investigations into uterine smooth muscle contrac-
tility, such as rings or strips [47].
Research using primary SMCs to develop 3D culture systems was first performed by Young 
et al. [48] in 2003. Young et al. [48] performed single- and two-mesh experiments to study 
human myometrial physiology. In the single-mesh experiments, myometrial SMCs were 
seeded onto a polyglactin-910 (Vicryl) mesh after several passages [48]. In order to avoid con-
tact with the plastic dish, each mesh was transferred to another culture dish after several days 
and suspended [48]. SMCs grew into and filled the pores of the mesh by repetitive prolifera-
tion, retraction, and proliferation [48]. A confluent, 3D tissue was attained 10–14 days after the 
initial seeding of the mesh [48]. In the two-mesh experiments, myometrial SMCs were seeded 
onto two layers of mesh and then cultured as described above [48]. SMCs not only grew into 
and filled the pores of each mesh, but also bridged between the two layers of mesh [48]. A 
confluent, 3D tissue was attained 2–3 weeks after the initial seeding of the mesh [48]. In the 
single-mesh experiments, average membrane potential of the cells was −35 ± 6 mV, and the 
thickness of the tissue was 9–40 μm (1–8 cells thick) within the pores of the mesh. In the two-
mesh experiments, the bridging SMCs were able to sustain a tension of 5 g/cm2 before separa-
tion of the two meshes occurred, as well as coordinated contractions of 40–200 cells [48]. SMCs 
grown in 3D using Vicryl mesh would therefore provide a model system for investigating the 
physiology of cell-to-cell interactions in human myometrium.
Malik et al. [49] developed human myometrium 3D cultures using a 3D collagen gel and 
examined the response of these cultures to external stimuli. Myometrial cells in 3D cul-
ture maintained the in vivo characteristics of the tissues they were derived from, as well 
as the characteristic fusiform of the SMCs [49]. That is, the cells exhibited long, tapering 
ends, resulting in a highly spindle-shaped phenotype, which stained positive for smooth 
muscle-specific α-actin and F-actin fibrils [49]. Previous studies have shown that TGF-β3 
treatment of myometrial cells in 2D culture resulted in up-regulation of various extracellular 
matrix genes [50, 51]. During 3D culture of myometrial SMCs, TGF-β3 treatment produced 
a similar up-regulation of extracellular matrix genes, thus demonstrating that the cells in 3D 
culture were similarly bioactive [49]. These results indicate that cells in 3D culture can be 
used to investigate aspects of human parturition and to assess the effectiveness of various 
treatments.
More recently, Souza et al. [52] used magnetic 3D bio-printing to create more complex 
shapes, such as rings, to imitate uterine smooth muscle. The process involved magnetizing 
primary SMCs with a biocompatible nanoparticle assembly consisting of gold, iron oxide, 
and poly-L-lysine, then aggregating the cells into hollow rings using magnetic forces [52]. 
Once aggregated, the cells interacted and built extracellular matrix to recapitulate native tis-
sue environments [52]. The bio-printed uterine rings contracted immediately after they were 
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removed off the magnet, which is consistent with the nature of the SMCs [52]. Furthermore, 
the tocolytic compounds, indomethacin and nifedipine, dose-dependently inhibited con-
tractions in the myometrial smooth muscle rings [52]. Magnetic 3D bio-printing therefore 
constitutes a novel model system that can serve as a valuable toolfor investigating human 
parturition [52].
A recent development in the sphere of 3D culture is the use of biological scaffolds derived 
from decellularized tissues and organs. Decellularization involves devoiding a tissue or 
organ of its inhabiting cells, leaving behind the extracellular matrix scaffold of the original 
tissue. This naturally occurring 3D biologic scaffold can be then recellularized with primary 
SMCs that will differentiate into the original type of tissue (Figure 3). This approach has 
been successfully used in animal studies as well as in human clinical applications [53–59], 
and more recently, in myometrium [60]. Young et al. [60] used tissue-engineering techniques 
to reconstruct allo- and xeno-neo-myometrium from isolated rat and human myocytes and 
Figure 3. Application of 3D culture and decellularization to reconstruct tissue strips. Human myometrial biopsies 
are utilized to prepare primary myocyte cultures, as well as dissected into strips. Primary myocyte number is amplified 
using traditional 2D culture, while the tissue strips undergo decellularization to obtain scaffolds. Isolated primary 
myocytes are then seeded back into the scaffolds and the 3D culture maintained. Once the myocytes have permeated the 
scaffold, the contractility of the reconstructed tissue strips can be examined using contraction bioassays. To investigate 
signaling networks, primary myocytes can be modified while in 2D culture to observe the effect on contractility. The 
reconstructed strips can also be subjected to desired treatments or experimental conditions. The strips can then be snap 
frozen or preserved for subsequent analyses.
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scaffolds. Allo-neo-myometrium was made from components of the same species (rat SMCs 
with rat scaffold; human SMCs with human scaffold), while xeno-neo-myometrium was 
made across species (human SMCs with rat scaffold) [60]. Myocytes were isolated using 
collagenase digestion, while scaffolds were isolated using ethanol/ trypsin protocols [60]. 
Isolated myocytes were amplified using monolayer culture and then cultured back into the 
scaffolds [60]. When human myocytes were cultured into human scaffold (allo-neo-myome-
trium), the myocytes overgrew each other after prolonged culture; nevertheless, they then 
separated, retracted, and never attained a thick layer of myocytes on the scaffold surface 
[60]. Rat myocytes cultured into rat scaffolds (allo-neo-myometrium) only formed multicel-
lular layers on the surface following artificially created defects in rat scaffold [60]. Human 
myocytes grown on rat scaffold (xeno-neo-myometrium) formed multicellular layers on the 
surface [60]. These surface multicellular layers were thick, and more importantly, bundles 
of cells were observed to depths of 500 μm within the rat scaffold [60]. This xeno-neo-myo-
metrium revealed structural integrity, good cellularity, as well as excellent cellular viabil-
ity [58]. Interestingly, isometric contractility experiments revealed that human myocytes 
on rat scaffold (xeno-neo-myometrium) produced coordinated contractions, while human 
myocytes cultured into human scaffold (allo-neo-myometrium) did not [60]. The construc-
tion of neo-myometrium, prepared through the recellularization of decellularized scaffolds, 
is a model system that enables researchers to examine the role of extracellular matrices in 
contractility [60]. Additionally, through performing genetic manipulation of the SMCs prior 
to recellularization, the approach may enable researchers to investigate the role of differ-
ent genes/proteins in myometrial contractility. Despite being an exciting avenue for future 
exploration, the production of neo-myometrium is complex, and to date, researchers have 
primarily utilized myometrial tissue strips or pieces to investigate the transition between 
uterine quiescence and contractility.
6. Tissue strip models
A model system frequently used to study pregnant human myometrium is the contraction 
bioassay, which uses strips of myometrium to study contractility ex vivo. Due to being freshly 
isolated intact pieces of tissue, ex vivo tissue strips arguably represent the in vivo phenotype 
more closely than other model systems. During the contraction bioassay, myometrial biopsies 
are typically obtained from the lower uterine segment of term singleton pregnancies during 
Cesarean section then dissected into strips (approximately 10 × 2 × 2 mm). The myometrial 
strips are connected to force transducers and lowered into organ baths containing a salt solu-
tion, such as Krebs–Henseleit buffer, which is continuously bubbled with 95% O
2
/5% CO
2
 and 
maintained at 37°C (pH 7.4). The contraction assay apparatus enables passive tension to be 
applied to individual strips. As a general protocol, myometrial strips are equilibrated for the 
first hour, during which the buffer is exchanged every 10 min and tension (1 g) is re-applied 
to strips after each wash. Following the equilibration period, strips are then left to develop 
spontaneous rhythmic contractions ex vivo. Once spontaneous rhythmic contractions have 
developed, the myometrial tissue strips can be used to analyze the effect of treatments on con-
tractility in real-time [61–63], as well as capture dynamic events that occur during contraction 
and relaxation, such as protein phosphorylation [64, 65] (Figure 4).
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Multiple studies have used myometrial tissue strips to analyze the effect of various treat-
ments on contractility. Ruddock et al. [66] exposed contracting myometrial strips to pro-
gesterone or 17-alpha-hydroxyprogesterone caproate (17P) to determine whether these 
hormones directly inhibit human uterine contractility in vitro. Progesterone dose-depend-
ently-inhibited uterine contractility, while 17P dose-dependently-stimulated contractility 
[66]. Similarly, Anderson et al. [61] also found that progesterone inhibited uterine contractil-
ity in vitro, however, in contrast to Ruddock et al. [66], they reported that 17P had no effect 
on uterine contractility [61]. Sexton et al. [67] also reported that 17P did not affect the contrac-
tility of pregnant or non-pregnant human myometrial strips. Although bioassay evidence 
suggests that 17P does not affect human uterine contractility directly, numerous clinical tri-
als have showed that administration of 17P is successful in preventing preterm delivery in 
high-risk women [68–70]. This positive clinical outcome could be mediated through long-
term genomic pathways that are not imitated during comparatively short-term organ bath 
studies. During organ bath studies, Anderson et al. [61] found that myometrial contractility 
began to decrease after 8 h incubation, presumably due to cell death and lack of energy 
substrates in the tissue; however, longer term studies by Young et al. [71] have shown that 
Figure 4. Myometrial tissue strip contraction bioassay. Human myometrial samples, collected during Cesarean section, 
are cleared of serosa, fibrous or damaged tissue and visible blood vessels then dissected into strips (~10 × 2 × 2 mm). 
The strips are then connected to a force transducer and lowered into organ baths containing a salt solution, which is 
continuously gassed with 95% O
2
/5% CO
2
 and maintained at 37°C (pH 7.4). The strips are equilibrated for the first hour, 
with washes and re-tensioning every 10 minutes. Strips are then left to develop spontaneous rhythmic contractions ex 
vivo. Upon recording a baseline of consistent contractions, desired treatments are applied to individual strips and the 
effects recorded. For subsequent analyses, strips can be snap frozen or preserved at the completion of the study, or at 
specific stages in relation treatment or contraction status.
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culturing myometrial strips under tension can maintain spontaneous contractility and oxy-
tocin responsiveness for up to 7 days.
Numerous tocolytics have also been tested using the contraction bioassay. Baumbach et al. [62] 
performed studies investigating the effects of a variety of contraction blocking drugs on term, non-
laboring myometrium in vitro, in both the presence and absence of progesterone. Progesterone 
alone had little inhibitory effect on contractility [62]. Nifedipine and indomethacin both signif-
icantly inhibited myometrial contractility alone, and to a greater extent when combined with 
progesterone [62]. These results indicated that combinations of progesterone with nifedipine 
or indomethacin might help in the prevention of preterm birth [62]. Another group also per-
formed in vitro studies using myometrial strips to determine the effect of progesterone and nitric 
oxide alone or in a combination [72]. Previous study had shown that nitric oxide inhibits human 
myometrial contractions in vitro [73]. The combination of progesterone with nitric oxide was 
significantly more effective at inhibiting uterine contractility than progesterone alone or nitric 
oxide alone [72]. These findings suggest that administration of progesterone in combination with 
nitric oxide could be more successful in the treatment of preterm labor than either agent alone 
and demonstrates that the contraction bioassay is an effective model for elucidating synergisms 
between different tocolytics. This could translate into the development of more effective strate-
gies for the prevention of preterm birth.
Recently, Paul et al. [74] developed the first drug delivery system targeting the pregnant uterus 
for preventing preterm birth. The team created liposomes loaded with various tocolytics, includ-
ing nifedipine, salbutamol and rolipram, as well as the contraction-promoting agent, dofetilide, 
and conjugated to an antibody that specifically recognized an extracellular domain of the oxyto-
cin receptor (OTR) [74]. Utilizing the contraction bioassay, Paul et al. [74] demonstrated that OTR-
targeted liposomes loaded with nifedipine, salbutamol or rolipram consistently abolished human 
myometrial contractions in vitro, while OTR-targeted liposomes loaded with dofetilide increased 
contraction duration [74]. Non-targeted control liposomes loaded with these agents had no effect 
on contractility in vitro [74]. Paul et al. [74] also utilized the contraction bioassay to demonstrate 
that targeted liposomes were similarly effective against mouse uterine tissue in vitro.
The contraction bioassay model can also be used to examine tissue responsiveness and con-
tractility after short- or long-term pre-treatment of myometrial strips. Fetalvero et al. [75] incu-
bated myometrial tissue strips for 48 h in the presence or absence of the prostacyclin analog, 
iloprost. Initially, tissue strips displayed irregular and infrequent spontaneous contractions; 
as such, oxytocin had to be added to initiate rhythmic contractions [75]. The study revealed 
that long-term pre-treatment of myometrial strips with iloprost resulted in increased con-
tractile responsiveness to oxytocin [75]. These results suggest that endogenous myometrial 
prostacyclin could play an important role in regulating myometrial activation, a crucial step 
in the initiation and progression of parturition [75]. Tyson et al. [63] revealed that corticotro-
pin-releasing hormone (CRH) inhibited contractility in preterm and term myometrial strips 
in vitro. Pre-treatment of term myometrial tissue strips for 1 h with progesterone significantly 
increased CRH-induced relaxation [63]. Furthermore, pre-treatment of term myometrial 
tissue strips for 1 h with rolipram, a selective phosphodiesterase-4 inhibitor, significantly 
increased both CRH- and salbutamol-induced relaxation [63]. This implies that CRH might 
be a facilitator in the transition of the myometrium from relaxation to contraction.
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In a novel application, Paul et al. [64] adapted the contraction bioassay to study the molecular 
regulatory events associated with contraction and relaxation in term pregnant human myome-
trium. In order to examine rapid phosphorylation and de-phosphorylation events that occur 
in phase with contractions, myometrial tissue strips were snap frozen at specific stages during 
the development of spontaneous contractions, including: (1) prior to the onset of any contrac-
tions, (2) at peak contraction and (3) during maximum relaxation between individual contrac-
tions [64]. The results showed that Caldesmon and ERK 1/2 were both phosphorylated during 
contractions and de-phosphorylated during periods of relaxation [64]. This application of the 
contraction bioassay provided a unique insight into phasic phosphorylation events that occur 
during spontaneous rhythmic myometrial contractions in humans. The study emphasized the 
importance of considering the contractile status of the tissue (contracted versus relaxed) dur-
ing experimental design and interpretation of results [64]. Hudson et al. [65] applied the meth-
odology developed by Paul et al. [64] to measure phosphorylation of MYL kinase (MYLK) and 
myosin phosphatase (MYLP) during spontaneous and oxytocin receptor (OXT)-stimulated 
phasic myometrial contractions in vitro. MYLK is activated by calcium-calmodulin, while 
MYLP is inhibited by phosphorylation of its myosin-binding subunit (MYPT1) by calcium-
independent mechanisms [65]. Hudson et al. [65] showed that in fresh human myometrial 
tissue strips, spontaneous and OXT-stimulated phasic contractions were associated with Rho-
associated kinase (ROCK)-dependent increases in phosphorylation of MYL and MYPT1 [65]. 
These findings provide new insight into uterine physiology and increase our understanding 
of the control of human myometrial activity.
While tissue strip models enable the real-time assessment of contractile properties of the myo-
metrium, assessment of contractility is not always necessary. For such studies, preparation of 
myometrium as small pieces, often called explants, is an attractive alternative as it represents 
a similar ex vivo model, while avoiding the complexity of subjecting the tissue to stretch.
7. Tissue pieces/explant models
Explants are pieces of tissue cut from an animal or plant and used to initiate a culture. The 
term ‘explant’ is perhaps incorrectly applied to human myometrium, at least in the context of 
this model, in that the small myometrial pieces are not used to establish an ongoing culture. 
Rather, the tissue pieces are used as an ex vivo model on which to directly perform relatively 
short-term studies (<7 days). For this reason, tissue ‘pieces’ is perhaps more appropriate, and 
will be utilized hereafter. When utilized to study human parturition, tissue piece models typi-
cally involve the collection of non-laboring or laboring pregnant human myometrium dur-
ing Cesarean section delivery, which is then dissected into small pieces (~3 × 3 × 3 mm) and 
incubated in Petri dishes or multi-well plates containing a nutrient media, such as Dulbecco’s 
Modified Eagle’s Medium (DMEM) [76–79]. The tissue pieces are then subjected to desired 
treatments or experimental conditions, after which the tissue pieces are snap frozen or pre-
served for subsequent analyses. Utilizing the tissue piece model, researchers can examine the 
effect of multiple treatments on a broad range of endpoints, including gene expression, protein 
levels and epigenetic modifications, as well as section the tissue to perform visualization stud-
ies (Figure 5). The number of treatments and endpoints that can be examined is limited only by 
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the amount of biopsied tissue available. The versatility and relative simplicity of the model has 
led to its extensive application to study human parturition. Fortunately, evidence indicates that 
the tissue piece model is more representative of myometrium in vivo than other in vitro models.
Georgiou et al. [80] compared gene expression in fresh myometrium, which was frozen at 
the time of Cesarean section, to ex vivo myometrial pieces, passage 4 primary myometrial 
cells, and hTERT myometrial cells. While whole-genome transcriptome analysis revealed 
that none of the in vitro models overlapped with the fresh tissue, in a principal component 
analysis plot [80], the gene expression profile of the tissue pieces most closely resembled 
that of the fresh tissue [80]. Upon direct comparison; 1444 genes varied between the ex vivo 
tissue pieces and fresh tissue; 3840 genes varied between passage 4 primary myometrial 
cells and fresh tissue; and 4603 genes varied between hTERT myometrial cells and fresh 
tissue [80]. A total of 555 genes varied commonly upon comparing all three in vitro groups 
(ex vivo tissue pieces, passage 4 primary myometrial cells and hTERT myometrial cells) to fresh 
tissue [80]. Georgiou et al. [80] validated the microarray results by examining genes associated 
with reproductive function and parturition, including PTGS2, OXTR, PGR and GJA1, as well 
as genes associated with the smooth muscle phenotype, including alpha smooth muscle actin 
(ACTA2) and MYL kinase (MYLK) [80]. PGR, OXTR and GJA1 mRNA expression did not vary 
significantly between the ex vivo tissue pieces and fresh tissue [80]. In contrast, PGR mRNA 
expression significantly decreased in both passage four primary myometrial cells and hTERT 
myometrial cells, compared to fresh tissue [80]. Moreover, in passage four primary myome-
trial cells, OXTR and GJA1 mRNA expression significantly decreased and increased, respec-
tively, compared to fresh tissue [80], while PTGS2 mRNA expression significantly increased 
in both tissue pieces and hTERT myometrial cells, compared to fresh tissue [80]. This was 
consistent with the gene ontology analysis, which indicated that there was an increase in genes 
associated with inflammation in all three in vitro models compared to fresh tissue [80]. ACTA2 
Figure 5. Myometrial tissue piece culture model. Human myometrial samples, collected during Cesarean section, are 
cleared of serosa, fibrous or damaged tissue and visible blood vessels, then dissected into pieces (~3 × 3 × 3 mm). The 
tissue pieces are incubated in Petri dishes containing a nutrient media (95% O
2
/5% CO
2
/37°C). Tissue pieces are then 
subjected to desired treatments or experimental conditions, after which the tissue pieces are snap frozen or preserved 
for subsequent analyses.
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and MYLK mRNA expression remained unchanged in ex vivo tissue pieces, compared to fresh 
tissue, whereas both were significantly decreased in hTERT myometrial cells, compared to 
fresh tissue [80]. Georgiou et al. [80] therefore concluded that myometrial ex vivo tissue pieces 
represent a superior model for studying human parturition over that of cell culture models.
It is important to note, however, that while evidence indicates that ex vivo tissue piece models 
are more representative of in vivo tissue than other models, recent studies demonstrate that 
ex vivo tissue pieces are not invulnerable to culture-induced changes. Ilicic et al. [81] exam-
ined whether myometrial tissue pieces undergo changes in key parturition-associated genes 
(ESR1, PTGS2 and OXTR) upon being incubated for 48 h ex vivo (DMEM, 95% O
2
/5% CO
2
, 
37°C, pH 7.4). Compared to fresh term non-laboring myometrium, the abundance of ESR1 
and PTGS2 mRNAs significantly increased after 48 h incubation [81], while OXTR expression, 
which was high in the fresh non-laboring tissue, significantly decreased after 48 h incubation 
[81]. These changes are of importance as myometrial expression of ESR1 [76, 82] and PTGS2 
[83, 84] increase with the onset of labor, while OXTR expression has been reported to decrease 
with advanced labor [84–87]. The gene expression changes observed during ex vivo incubation 
of term non-laboring myometrial tissue pieces are therefore consistent with the tissue transi-
tioning to a labor-like state.
In light of these findings, Ilicic et al. [88] further examined whether myometrial tissue pieces 
undergo culture-induced changes in PGR isoform expression that are consistent with transi-
tion to a pro-contractile, labor-like phenotype. It was revealed that progesterone receptor A 
(PR-A) mRNA abundance increased after just 1 h culture, whereas progesterone receptor B 
(PR-B) mRNA abundance remained constant [88]. The net effect was a statistically significant 
increase in the PR-A/PR-B expression ratio after just 6 h of in vitro incubation [88]. This was con-
sistent with previous reports that PR-A protein abundance increased during labor, while levels 
of PR-B were not altered by labor status [89]. Furthermore, it has been shown that the onset of 
labor is associated with increased abundance of PR-A mRNA, and an increase in the PR-A/PR-B 
expression ratio in term human myometrium [82]. The observation that PR-A mRNA abun-
dance and the PR-A/PR-B expression ratio significantly increased during in vitro incubation is 
therefore once again consistent with the non-laboring tissue pieces transitioning to a labor-like 
state as a consequence of in vitro conditions [88]. Performing in vitro experiments using myo-
metrium that is in a state of flux is not ideal, and raises the possibility that the relevant litera-
ture may contain findings reported for ‘non-laboring’ tissue that were in fact obtained with 
myometrium that was actively transitioning, or had already transitioned to, a laboring phe-
notype. To address this, the authors sought to identify culture conditions that could be imple-
mented to maintain a non-laboring state, whereby ex vivo myometrial tissue pieces retained 
high OXTR mRNA expression, low ESR1, PTGS2 and PR-A mRNA expression, as well as a 
low PR-A/PR-B expression ratio (<1; a PR-B dominant state), thereby providing a more appro-
priate in vitro model for conducting studies into myometrial biology [81, 88]. Adding proges-
terone to culture media prevented the culture-induced increase in ESR1, but failed to prevent 
culture-induced increases in PTGS2 [81]. Culture-induced decrease in OXTR expression was 
prevented by supplementing media with PMA, however, this was concurrent with further up-
regulation of PGTS2 expression toward a laboring phenotype [81]. Culture-induced increase of 
PTGS2 expression in vitro was not counteracted by any of the treatments examined, including 
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supplementation with NF-κB inhibitors [81]. A combination of progesterone and estrogen pre-
vented the culture-induced increase in PR-A, but failed to prevent significant increase in the 
PR-A/PR-B expression ratio as PR-B expression was also reduced [88]. Stretch blocked the effects 
of steroids on PR-A expression [88]. Perhaps most importantly, supplementing media with the 
histone deacetylase inhibitor (HDACi), trichostatin A (TSA), prevented the culture-induced 
functional progesterone withdrawal phenomenon by maintaining a low PR-A/PR-B expression 
ratio, consistent with maintenance of a non-laboring phenotype in the ex vivo tissue pieces [88]. 
Similarly, Georgiou et al. [80] attempted to mimic physiological conditions as closely as pos-
sible by supplementing culture media with steroids and the adenylyl cyclase agonist, forskolin, 
but found that this had no effect on maintaining PGR levels in vitro. Culture-induced changes 
in ESR1, PTGS2, OXTR and PGR expression could not be controlled simultaneously [81, 88]. 
The implications are potentially significant as findings made using ‘non-laboring’ tissue may 
in fact have been generated using tissue that was no longer representative of the non-laboring 
phenotype, which could affect experimental outcomes.
Interestingly, rapid transition away from the non-laboring phenotype could be a requisite 
for contraction bioassay models. That is, upon suspending strips of freshly isolated term, 
non-laboring myometrium in organ baths, connected to force transducers, the strips initially 
show little to no contractility. Spontaneous contractions then progressively develop over 
time, ultimately becoming consistent and rhythmic after 1–2 h. This suggests that the tissue 
strips may be rapidly transitioning away from a non-laboring phenotype toward a labor-like 
phenotype [61, 63–67, 71, 74]. Additional studies are necessary to determine whether this 
indeed is the case.
Model Advantages Disadvantages
Primary myometrial 
smooth muscle cell 
culture model
• Cost effective
• Straightforward/easy procedure
• Easy downstream processing (cell extrac-
tion, imaging of cells)
• Not representative of 3D in vivo 
environment
• Reduced cell-to -cell interaction
• Short period of viability
• Low biological relevance
• Susceptible to contamination
Immortalized 
myometrial smooth 
muscle cell culture 
model
• Can be maintained for prolonged 
periods
• Extended and indefinite growth in vitro
• Cost effective
• Increased growth rate
• Easy downstream processing
• Not representative of 3D in vivo 
environment
• Immortalization alters cell characteristics 
and functions
• Low biological relevance
• Susceptible to contamination
• Decreased cell size
Stretch-based culture 
model (Flexercell)
• Mimics in vivo stretch
• Defined and controlled deformations of 
cells in vitro
• Straightforward/easy procedure
• Not representative of 3D in vivo 
environment
• Reduced cell-to -cell interaction
• Low biological relevance
• Susceptible to contamination
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Regardless of the whether uterine smooth muscle cells and tissues are in a state of flux during 
experimentation, it is apparent that each model system is associated with key advantages and 
disadvantages (Table 1). These include factors such as cost, ease of use, relevance to the in vivo 
situation, ability to be coupled with other techniques, downstream processing and more, and 
should be taken into consideration when selecting model systems.
8. Conclusion
Successful pregnancy necessitates that the uterus is maintained in a relaxed, quiescent 
state for the majority of pregnancy, before being transformed to a contractile and excitable 
Model Advantages Disadvantages
3D culture model • Depicts 3D environment
• Cell-to-cell interaction
• Cells interact with extracellular matrix
• More likely to represent the in vivo 
phenotype
• Expensive
• Long production times
• Large array of scaffold materials to trial 
and optimize
• Requires specialized equipment
• Lacks complex shapes
• Long downstream processing
• Extraction and imaging of cells hampered 
by culture depth
Tissue strip model 
(contraction bioassay)
• Representative of in vivo phenotype in 
the short-term
• Multiple treatments can be assessed
• Real-time assessment of contractility
• Effects of treatments observed in 
real-time
• Tissue-to-tissue variation
• Organ baths not sealed, therefore suscep-
tible to contamination
• Decreased myometrial contractility follow-
ing prolonged incubation
• Complex procedure
• Requires expensive specialized equipment 
(organ bath contraction apparatus, analysis 
software)
• Limited capacity to manipulate cells prior 
to the contraction assay
Tissue pieces model • More representative of the in vivo pheno-
type than 2D cultured cells
• Cost effective
• Straightforward/easy procedure
• Controlled culture conditions
• Multiple treatments can be assessed 
simultaneously
• Tissue-to-tissue variation
• Long downstream processing (mRNA/
protein isolation, tissue sectioning and 
imaging)
• Unable to assess stretch/contractility as an 
endpoint
Table 1. Advantages and disadvantages of model systems used to study pregnant human uterine smooth muscle.
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phenotype to facilitate parturition. Despite our rapidly advancing knowledge of myo-
metrial biology, the exact mechanisms that regulate parturition are not yet understood. 
Characterizing the complex interactions that form the key regulatory pathways control-
ling uterine quiescence, contractility and the transition between the two states is therefore 
essential to understanding normal human birth, as well as obstetric complications, includ-
ing preterm labor. In vitro models, such as myometrial SMC lines and ex vivo tissues, have 
been important tools for investigating these complex interactions. Nevertheless, recent 
evidence has shown that both primary cell lines and ex vivo tissues undergo culture-
induced changes in expression of key myometrial genes. For that reason, further studies 
are warranted to determine appropriate culture conditions that could prevent or attenuate 
the changes, thus providing researchers with a stable platform on which to investigate 
myometrial biology. Until then, researchers should remain mindful of the limitations of 
myometrial cell and ex vivo tissue models, and be cautious when interpreting the rel-
evance of results toward understanding human parturition.
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